Astrazeneca AZN
NYSE AZN
$172.60 +4.17 (+2.48%)
At close: Oct 22, 2026 · 4:00 PM EDT

Astrazeneca (AZN) Depreciation and Depletion (2011 - 2013)

Updated

Astrazeneca (AZN) posted Depreciation and Depletion of $7.22 billion for Q4 2018, up 2.8% from $7.02 billion a year earlier.

Analysis

Astrazeneca (AZN) Depreciation and Depletion (2011 - 2013) Analysis & Trends

For the trailing twelve months through Dec 31, 2018, Depreciation and Depletion at Astrazeneca was $28.28 billion, down 1.8% year-over-year.

  • The Q4 2018 figure stands as the highest quarterly Depreciation and Depletion since Q4 2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Depletion (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn -
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn -
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn 194.00 Mn
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn -
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn -
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn -
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn 98.00 Mn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn -
10 Vertex Pharmaceuticals 133.42 Bn 105.43 Bn 2.84 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 9.09 Bn
Dec 31, 2012 8.98 Bn
Dec 31, 2011 8.89 Bn
API Access

Astrazeneca Depreciation and Depletion API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=AZN&period=max&api_key=YOUR_API_KEY